|
|
Post by brotherm1 on Aug 24, 2016 11:16:49 GMT -5
Curious as to who or what prompts the FDA to set up and schedule these public workshops. Also curious as to why this one has a topic "beyond A1c"? Anyone here going to be close to Silver Spring MD on the 29th? www.fda.gov/ForPatients/Calendar/ucm501883.htm |
|
|
|
Post by logel on Aug 24, 2016 11:32:49 GMT -5
|
|
|
|
Post by brotherm1 on Aug 24, 2016 11:40:26 GMT -5
|
|
|
|
Post by rockstarrick on Aug 24, 2016 11:40:47 GMT -5
Looks like Mike C will be attending.
|
|
|
|
Post by bradleysbest on Aug 26, 2016 10:45:47 GMT -5
Does anyone know someone that submitted a video? This could be a really good thing for Afrezza.
|
|
|
|
Post by goyocafe on Aug 29, 2016 11:42:36 GMT -5
Does anyone know someone that submitted a video? This could be a really good thing for Afrezza. Anyone there that can give a flavor for this meeting? Would like something to get rid of the bad taste in my mouth. 😜 |
|
|
|
Post by kc on Aug 29, 2016 11:48:02 GMT -5
|
|
|
|
Post by peppy on Aug 29, 2016 11:49:47 GMT -5
I think its on line to watch and listen too kc or all, can you come up with a link?
|
|
|
|
Post by otherottawaguy on Aug 29, 2016 13:51:43 GMT -5
The links above seem to be working.
FDA site says that a transcript will be avail 30 days following the conference.
|
|
|
|
Post by peppy on Aug 29, 2016 15:18:11 GMT -5
|
|
|
|
Post by sluggobear on Aug 29, 2016 15:22:33 GMT -5
The links above seem to be working. FDA site says that a transcript will be avail 30 days following the conference. I'm seeing lots of Twitter posts with the @beyonda1c link that describe the proceedings. |
|
|
|
Post by roseylv on Aug 29, 2016 15:23:10 GMT -5
Peppy,
It's a bit hard to hear. Any cliff notes for those of us slammed in our work lives?
Thanks to Patten!
|
|
|
|
Post by goyocafe on Aug 29, 2016 17:29:01 GMT -5
Was there any part of today's meeting that addressed access to medications? From the parts I was listening to, there was little attention paid to the current situation getting (and keeping) affordable access to medications, and in the case of Afrezza, it seems this is one of the biggest challenges they've faced.
|
|
|
|
Post by johnhindepost on Aug 29, 2016 17:42:29 GMT -5
3:30-4:15 pm- ROUND TABLE DISCUSSION: LESSONS LEARNED, WITH STAKEHOLDERS George Grunberger, MD. Immediate Past President, American Association of Clinical Endocrinologists George Grunberger, MD. makes references toward Inhaled Insulin. Bad audio, anyway, a few lines "A1C is not the most important aspect of the treatment. Take for example of Inhaled Insulin. Anytime a patient might take the two or three meals a day. It works wonderful and it's beautiful. That's a beautiful risk course post prandial glycemia. It achieves its goal but the respected A1C dosen't seem affected by that. It makes no sense. ...........  ??............................. But unfortunately A1C has become such a measure." |
|
??............................. But unfortunately A1C has become such a measure."